Oncolytics Biotech Inc
TSX:ONC
Income Statement
Earnings Waterfall
Oncolytics Biotech Inc
Revenue
|
0
CAD
|
Operating Expenses
|
-33.8m
CAD
|
Operating Income
|
-33.8m
CAD
|
Other Expenses
|
6m
CAD
|
Net Income
|
-27.8m
CAD
|
Income Statement
Oncolytics Biotech Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(24)
|
(22)
|
(22)
|
(21)
|
(19)
|
(17)
|
(16)
|
(15)
|
(15)
|
(14)
|
(14)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(16)
|
(16)
|
(17)
|
(17)
|
(19)
|
(19)
|
(20)
|
(21)
|
(21)
|
(24)
|
(25)
|
(26)
|
(27)
|
(27)
|
(26)
|
(27)
|
(26)
|
(26)
|
(27)
|
(27)
|
(28)
|
(33)
|
(34)
|
|
Selling, General & Administrative |
(0)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(1)
|
(10)
|
(12)
|
(12)
|
(2)
|
(12)
|
(13)
|
(13)
|
(13)
|
(12)
|
(12)
|
(11)
|
(11)
|
(12)
|
(12)
|
(15)
|
(16)
|
|
Research & Development |
(18)
|
(14)
|
(14)
|
(16)
|
(14)
|
(12)
|
(11)
|
(10)
|
(9)
|
(9)
|
(8)
|
(8)
|
(10)
|
(9)
|
(11)
|
(11)
|
(9)
|
(10)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(12)
|
(13)
|
(13)
|
(14)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(15)
|
(15)
|
(16)
|
(18)
|
(18)
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Operating Expenses |
(5)
|
(6)
|
(7)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(24)
N/A
|
(22)
+6%
|
(22)
+2%
|
(21)
+7%
|
(19)
+10%
|
(17)
+8%
|
(16)
+6%
|
(15)
+7%
|
(15)
+3%
|
(14)
+0%
|
(14)
+6%
|
(13)
+3%
|
(15)
-15%
|
(15)
+2%
|
(16)
-11%
|
(16)
0%
|
(16)
+5%
|
(17)
-8%
|
(16)
+4%
|
(16)
0%
|
(17)
-6%
|
(17)
+3%
|
(19)
-11%
|
(19)
-1%
|
(20)
-8%
|
(21)
-4%
|
(21)
-1%
|
(24)
-13%
|
(25)
-5%
|
(26)
-1%
|
(27)
-5%
|
(27)
+1%
|
(26)
+2%
|
(27)
-2%
|
(26)
+3%
|
(26)
+0%
|
(27)
-4%
|
(27)
-2%
|
(28)
-4%
|
(33)
-18%
|
(34)
-1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
0
|
1
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
1
|
0
|
0
|
0
|
(13)
|
(7)
|
(8)
|
(8)
|
3
|
(4)
|
(3)
|
(1)
|
(0)
|
0
|
2
|
2
|
2
|
3
|
2
|
1
|
6
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(24)
N/A
|
(22)
+5%
|
(22)
+1%
|
(21)
+7%
|
(19)
+10%
|
(17)
+10%
|
(16)
+5%
|
(14)
+11%
|
(14)
+2%
|
(14)
-3%
|
(13)
+9%
|
(13)
-4%
|
(15)
-13%
|
(15)
+3%
|
(16)
-12%
|
(16)
+2%
|
(15)
+4%
|
(17)
-7%
|
(16)
+4%
|
(16)
-2%
|
(16)
-1%
|
(17)
-2%
|
(18)
-9%
|
(19)
-1%
|
(33)
-79%
|
(28)
+16%
|
(29)
-6%
|
(33)
-11%
|
(23)
+31%
|
(29)
-30%
|
(30)
-1%
|
(28)
+6%
|
(26)
+6%
|
(27)
-1%
|
(24)
+8%
|
(24)
+2%
|
(25)
-3%
|
(24)
+1%
|
(27)
-10%
|
(32)
-21%
|
(28)
+14%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(24)
|
(22)
|
(22)
|
(21)
|
(19)
|
(17)
|
(16)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(17)
|
(18)
|
(19)
|
(33)
|
(28)
|
(29)
|
(33)
|
(23)
|
(29)
|
(30)
|
(28)
|
(26)
|
(27)
|
(24)
|
(24)
|
(25)
|
(24)
|
(27)
|
(32)
|
(28)
|
|
Net Income (Common) |
(24)
N/A
|
(22)
+5%
|
(22)
+1%
|
(21)
+7%
|
(19)
+10%
|
(17)
+10%
|
(16)
+5%
|
(14)
+12%
|
(14)
+2%
|
(14)
-3%
|
(13)
+9%
|
(13)
-4%
|
(15)
-13%
|
(15)
+3%
|
(16)
-12%
|
(16)
+2%
|
(16)
+3%
|
(17)
-7%
|
(17)
+1%
|
(17)
-2%
|
(17)
0%
|
(17)
-2%
|
(18)
-6%
|
(19)
-1%
|
(33)
-79%
|
(28)
+16%
|
(29)
-6%
|
(33)
-11%
|
(23)
+31%
|
(29)
-30%
|
(30)
-1%
|
(28)
+6%
|
(26)
+6%
|
(27)
-1%
|
(24)
+8%
|
(24)
+2%
|
(25)
-3%
|
(24)
+1%
|
(27)
-10%
|
(32)
-21%
|
(28)
+14%
|
|
EPS (Diluted) |
-2.68
N/A
|
-2.51
+6%
|
-2.42
+4%
|
-2.21
+9%
|
-2.01
+9%
|
-1.59
+21%
|
-1.31
+18%
|
-1.12
+15%
|
-1.16
-4%
|
-1.15
+1%
|
-1.03
+10%
|
-1.06
-3%
|
-1.2
-13%
|
-1.15
+4%
|
-1.22
-6%
|
-1.09
+11%
|
-1.12
-3%
|
-1.12
N/A
|
-1.07
+4%
|
-1.02
+5%
|
-1.06
-4%
|
-0.93
+12%
|
-0.9
+3%
|
-0.81
+10%
|
-1.5
-85%
|
-0.74
+51%
|
-0.74
N/A
|
-0.78
-5%
|
-0.56
+28%
|
-0.59
-5%
|
-0.54
+8%
|
-0.5
+7%
|
-0.49
+2%
|
-0.48
+2%
|
-0.44
+8%
|
-0.43
+2%
|
-0.43
N/A
|
-0.41
+5%
|
-0.41
N/A
|
-0.46
-12%
|
-0.37
+20%
|